waiting game.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Artepharm Global (artepharmglobal.com) vs. Artehparm Co. LTD (artepharm.com)
I have sent off some emails to each website because I'm not sure what the relationship is between them. ARGC stated in their 10K that they were attempting to acquire the patent but the people who currently hold the patent is a company with offices in China, Nigeria, Comoros, Kenya and Cambodia. The company share the same name as ARGC and our new president Dr. Song has relations with Guangzhou University of Chinese Medicine which is where Artepharm Co. LtD's principle office is.
The Chinese company seems to have substantial financing which is not reflected in any of the 10K documents filled with the SEC. It's great news if ARGC is their North American partnership or if they are attempting something similar to a reverse merger but I'd like the relationship to be more clear.
Looks like your sources were not valid. No "very big day" today!
"cyclical nature of business brokerage"
What happened to those millions of dollars in contracts? Now the business is cyclical?
Post Unavailable
Additional Information
Yep, not arguing with you on this one haha. It's definitely a risk. It really depends on who funds them to do this. Someone has already completed one of the most expensive part, the R&D. The drug exists and it is presumably patented somewhere (probably China). Artequick has had highly successful field testing, along with a clinical trial (non-US). The base component is still Artemisinin, so I don't see this failing any clinical trials for scientific reasons. Political.. well that is a whole 'nother ball game when talking about communist countries influence in Africa vs. western medicine "charity" in Africa. There will be some clashing if this ever gets serious.
The life cycle of biopharma companies is exactly this. No profits or revenues and then a sudden spike, usually followed by a sell-off.
I'm not optimistic enough to think that the WHO is not a political organization and that other drug companies won't have a serious interest in preventing this drug from succeeding. Artemisinin is huge business in countries with Malaria and they aren't going to take kindly to having a new company present a drug that is essentially Artemisinin+ and not distributed by Pfizer and GlaxoSmithKline.
Lots of risk here. I think I'll definitely see a return on my investment from these levels and in the penny stock world 1% is acceptable haha.
Interest is picking up a bit this afternoon and I'm hoping a PR will bring us some spotlight on Monday.
At the moment http://www.ivyleagueotc.com/ and "StockProfitz" that has several handles on twitter have been pumping ARGC. Ivyleague has the most indepth analysis indicating a PR blitz is to begin but they are not specific about dates.
In theory that means that as of now 13,459 people are receiving these "tweets" about the stock but there has been little buying interest. I'm hoping it will be enough to generate interest when a good PR comes by.
Sorry I keep replying to everything, I'm bored haha.
Yes. It's interesting but the WHO concerns should be noted. We don't know how far along the drug has come since that piece was filmed in 2009. I did find a few peer reviewed studies, which the WHO specifically mentioned did not exist in the dateline video. So, some progress has been made.
You are right this is not a simple play.
Good points. They also have to work out a deal to acquire the patent and I don't imagine that is going to come cheap.
The President of the company is also president of another company that share their office, a mining company ironically, that seems to operate in the same areas they would want to use artequick. Perhaps they will secure financing with that company.
The most obvious thing is that the PR campaign is to get more investors and interest in the stock and the shareholders will be financing the bulk of their acquisition and expansion.
We are starting with a barebones report from 2009 but I am hoping things have happened in 2010 and this PR will be a big enough boost to get things rolling. I will probably hop out if this PR really is big (or if it comes at all!) and then get back in with a safer position.
Artequick has been field tested and peer reviewed as being more successful than the current treatment for Malaria. The Chinese government allowed them (not ARGC specificallym but Dr. Jianping Song) to test the drug on an island and it significantly reduced the rates of Malaria (22 to 4% with no deaths in a year (2009)).
10Q posted with SEC. Nothing too surprising. Just to note that they are a new company and in a highly competitive field. They are in talks to get the patent for Artequick and distribution rights. Let's see what the PR's say... I'm still on board.
Well, I definitely hope you are right. Regardless an investor just needs to look at what this company is doing and will see the potential here.
Yeah. I"m the opposite, I keep getting out before they run. I'm forcing myself to sit tight until the 10Q and then I will reassess.
Well they don't put out a lot of PRs so it really is just speculation. There is almost nothing available aside from the SEC fillings.
The "rumors" indicate that they are getting serious about financing. I don't think the 10Q is going to reflect an increase in financing but rather a starting point to indicate they are seeking financing and then a PR camp will start.
Yeah, me too. My confidence in the company will determine how much I reinvest or if I just want to free ride this.
My suggestion is ARGC. Rumors seem to be that they are pushing for a big round of financing soon. They have a small loan from a shareholder, who I expect is the CEO to keep things running now. They have developed a combination therapy that is more effective than the leading anti-malaria agent used around the world. They tested it on an island off mainland China in 2009 and brought the Malaria rate from 22% to 4% and hoping to zero. Regardless no one has died from Malaria there in a year now. The stock is a true penny stock at 40 cents/share. The guy who developed all this just took over as President of the company. They don't release PRs often but have positive peer reviewed findings on their drug and were featured on Dateline, though that was before they were incorporated in the US.
Anyway, that is my plug :P
Here's to a new BMW haha.
I like the company and I'm normally very skeptical. So far I see good things in DD and it would be nice to be part of a company that is actually going to help people instead of kill them for a change!
I removed the company name to adhere to TOU and I also don't like this company.
X announced today that on March 31, 2010 it filed its "Issuer Information and Disclosure Statement" on Pink OTC Markets, Inc. The "Caveat Emptor" designation has been removed and the Company's status is now designated "Limited Information." While the information posted is "current," X status has not been elevated to "Pink Sheets Current Information" because Pink OTC Markets provided an exemption to the Company from having to have an attorney's opinion letter (with approximate cost to the company totaling $5,000-$10,000). X is now able to post financial disclosure and current information and the quotation for X common stock has been restored to otcmarkets.com. The filing is also posted on x website. It contains up to date information on the Company as well as certified financial statements.
An opinion letter costs between $10,000 - 20,0000 as well.
10-Q due out today
Cross your fingers for a PR camp start as well.
Grrr. Why do they keep doing that. They did the same thing for SKGO. It's fraud. They didn't even both to change the interest and reflect monthly debts.
/sigh.
Also there won't be any combined balance sheets because they never filled the forms necessary to merge the companies with the SEC.
Well for your sake maybe we will dip to .35 but support levels are holding at .38 though there is very very small volume so far.
We are waiting on a 10K. I'm hoping it comes out with the start of their PR campaign. They are based in British Columbia so they don't normally put PRs and fillings out until 11 am EST, 9 am PDT.
I hope so. The stock service I use has about 15,000 followers and they have sent out about 15 messages urgently telling people to invest in ARGC. They obviously couldn't say if they had insider information but their last 10 picks netted at least 100% gains soo, I'm going with them haha.
1.) Right. They need to address that further.
2.) Retained earnings are what is left over once expenses are paid. It is not the same as net income because retained earnings (or losses) accumulate. So the formula is Beginning Retained earnings + net income.
We knew Sanhe would have positive retained earnings, that is not really news. However, when you add in the expenses from SITG retained earnings would be lower, if not negative. Bear in mind that they haven't even filled the appropriate documents with the SEC outlining this merger in the first place. They need to do that and them hopefully merge the financial data into one company.
oh god real news
get the defibrillator I'm goin down
No worries. The more people in the know the better. The worst thing that can happen is misinformation here.
They must file a 13D within 10 days of becoming a 5% owner of shares.
http://www.ria-compliance-consultants.com/form13f_section_13d_schedule_13g.html
That website is published by a team of SEC experts.
---
The second matter is that in order to be considered a mini-tender offer under the SEC guidelines, and avoid much of the reporting necessary under a tender offer they cannot at ANY time purchase more than 5% of the outstanding shares. If they do, they must file with the SEC and are subject to all of Rule 14 of the SEC act of 1934.
Yes. That is a positive thing for this deal. I remember when a company I was working for completed a major merger. The takeover company said "We at Company A love our employees at Company B and plan to keep you all"
Three months later they have layed off, terminate or forced resignations from all the employees at Company B. <3 Corporate America
Well not if another OTC company was buying them but if a company listed on the major indicies is a buyer.. holy jesus. In which case you would be left with a scenario of the buyout needing to be renegotiated because of the higher PPS. THRR wouldn't sell their company for .01/share if the PPS is .05+/share.
I should mention that my position is not that this company is a scam but rather there is still the strong and likely possibility that they will not complete the deal.
Near impossible without the PPS going to .01 or beyond as a result. If they bought more than 5% of the company they have to file with the SEC as soon as they reach 5% ownership. That would give them away as the buyer and it would greatly influence the deal.
Done. In at 0.38 - .40.
The entire day has been buys. No sells.
Post Unavailable
Additional Information
Promises. Promises. Promises.
Even when I had an inventory of 69,000 books, I only sold about $800/week and maybe 1500 during Christmas. This is because the books that are the cheapest make you the most money but they are often not the books in demand. He doesn't know a think about the bookselling business and will easily end up with thousands of titles he can't sell. They can apply for a wholesaler license but will be lucky to see a 5% profit off any new titles being printed. They also have to compete with ALOT of people selling books. Many of whom have programs that automatically adjust their prices to beat you. This is not something to finance a corporation. This is something to finance a person or small group.
I should also point out there is another company listed on the pinks that sells items on ebay and their PPS is scarcely higher than MDIN.
If I get in on MDIN at .0001, then I will look at the upside. Until then, there is a downside to investing in this stock.
LOL.
I'm so going to be called a basher here but 5,000 titles on Amazon is nothing. That is maybe $1,000/month in sales. I know this because selling books is how I generate a fixed income for investing. They could be selling 5,000 books that no one wants.
So now they are a "business broker" in debt and a book seller lol. Hot dog stands and ATMS are next?
Source?
That report is best understood as "earnings report due out" -- they aren't required to release the info. I think if it was going to be show stopping they would have mentioned the numbers in PRs. I think it will still be good but not amazing.
Yes and I confirmed that with CCTR's IR.
My order is in for 54k at ask.
The report needs to indicate that they have improved their profit margin. Right now it is paper thin. It doesn't matter if you have 6 billion in revenue if you only have a 1% profit margin.
lol maybe he meant over...